8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
An expert overview of the literature, useful as background reading.
2014 / Literature review
This literature review assessed international studies from PubMed and Medline to define current pathogenic, clinical, and diagnostic criteria for non-celiac gluten sensitivity (NCGS). Most NCGS patients report both gastrointestinal and nongastrointestinal symptoms that improve on a gluten-free diet, although they test negative for celiac disease and wheat allergy. NCGS patients represent a heterogeneous group, and diagnosis currently requires excluding celiac disease and wheat allergy. Features such as infant food allergy history, coexistent atopy, positive IgG antigliadin antibodies, basophil activation tests, and intestinal eosinophil counts may help identify these patients.
Mansueto P, Seidita A, D'Alcamo A, et al. J Am Coll Nutr, 2014. PMID 24533607
2014 / Narrative review
This review summarizes hidradenitis suppurativa (HS), a chronic, relapsing, inflammatory skin condition typically occurring after puberty with an estimated worldwide prevalence of 1-4%. It is three times more common in women than men and presents as painful inflamed nodules progressing to abscesses and scarring. Recognized risk factors for HS include smoking and obesity, and comorbidities include inflammatory bowel disease and spondyloarthropathies.
Shows an association, not proof of cause and effect.
Dufour DN, Emtestam L, Jemec GB Postgrad Med J, 2014. PMID 24567417
2014 / Narrative review
This review evaluates complementary and alternative medicines (CAM) alongside pharmacological options for irritable bowel syndrome (IBS). Clinical trials over the past decade show that specific herbal therapies (peppermint oil and Iberogast), hypnotherapy, cognitive behavior therapy, acupuncture, and yoga provide improved treatment outcomes. The authors propose an integrative approach combining pharmacotherapy with CAM to optimize patient care and quality of life.
Grundmann O, Yoon SL World J Gastroenterol, 2014. PMID 24574705
2014 / Narrative review
This review discusses the interactions between diet, gut microbiota, and host immune functions in relation to metabolic disorders. The gut microbial composition changes dynamically in response to factors such as host genetics, age, and environment. Dietary regulation affects microbial metabolism and host immunity via mechanisms including nutrient fermentation, intestinal barrier function, gene expression, and immune responses. Modulating gut microbiota through diet patterns, probiotics, prebiotics, and antibiotics shows potential for preventing obesity.
Chen J, He X, Huang J J Food Sci, 2014. PMID 24621052
2014 / Narrative review
This review details how obesity and related metabolic conditions contribute to hepatocarcinogenesis. Obesity-associated hepatocellular carcinoma is attributed to chronic inflammation from adipose remodeling, pro-inflammatory adipokine secretion, ectopic lipid accumulation, altered gut microbiota, disrupted stellate cell senescence, and insulin resistance with elevated insulin and insulin-like growth factors. These pathways synergize with chronic liver disease from other etiologies to accelerate hepatocellular carcinoma development.
Shows an association, not proof of cause and effect.
Karagozian R, Derdák Z, Baffy G Metabolism, 2014. PMID 24629562
2014 / Narrative review
Seaweeds are rich in unique bioactive compounds such as specific proteins, polyphenols, and polysaccharides with purported antiviral, anticancer, anticoagulant, gut health, obesity, and diabetes benefits. Although most research has been conducted in cell and animal models, evidence exists for the beneficial effects of seaweed and seaweed components on markers of human health and disease status. This review critically evaluates these human studies to highlight gaps in current knowledge and support future research planning.
Brown ES, Allsopp PJ, Magee PJ, et al. Nutr Rev, 2014. PMID 24697280
2014 / Narrative review
This review evaluates the role of calcium supplements in osteoporosis prevention. While calcium acts as a weak antiresorptive and slows postmenopausal bone loss, recent meta-analyses indicate no significant prevention of fractures. Meanwhile, supplement use is likely associated with increased cardiovascular events, kidney stones, gastrointestinal symptoms, and hospital admissions for acute gastrointestinal issues. Consequently, the review suggests obtaining calcium from dietary sources instead, noting that dietary calcium has not been linked to the adverse effects seen with supplements.
Reid IR J Bone Metab, 2014. PMID 24707464
2014 / Narrative review
This review examines the influence of dietary and environmental factors, alongside gut microbiota, on type 1 diabetes (T1D) etiology in humans and animal models. Even in mono-zygotic twins, the concordance rate is only around 50%, highlighting the role of non-genetic factors. Although data remain inconclusive, there are strong indications that gut microbiota dysbiosis plays an important role, and animal models suggest manipulating the gut microbiota may be valuable for future prevention in genetically susceptible individuals.
Nielsen DS, Krych Ł, Buschard K, et al. FEBS Lett, 2014. PMID 24746688
2014 / Narrative review
This review discusses the relationship between gut microbiota, obesity, and type 2 diabetes (T2D). Human metagenome-wide association studies show significant correlations between specific intestinal bacteria, bacterial genes, and metabolic pathways with T2D. Notably, concentrations of butyrate-producing bacteria such as Roseburia intestinalis and Faecalibacterium prausnitzii were lower in T2D subjects. Additionally, gut-derived endotoxaemia is observed in metabolic syndrome and T2D, and specific bacteria like Akkermansia muciniphila may be decreased in diabetes and exert antidiabetic effects in murine models.
Shows an association, not proof of cause and effect.
Tilg H, Moschen AR Gut, 2014. PMID 24833634
2014 / Narrative review
This review evaluates pharmacological and non-pharmacological treatment options targeting the central nervous system and gastrointestinal tract for irritable bowel syndrome (IBS) abdominal pain. A diet low in fermentable carbohydrates and polyols (FODMAP) seems effective in subgroups of patients to reduce abdominal pain and bloating and improve stool pattern, while fiber evidence is limited with only ispaghula showing some benefit. Antispasmodics, including peppermint oil, remain first-line treatments for abdominal pain, alongside various second-line therapies tailored to IBS subtypes.
Vanuytsel T, Tack JF, Boeckxstaens GE J Gastroenterol, 2014. PMID 24845149
2014 / Narrative review
This review examines the influence of dietary patterns and their components on the gut microbiota and cardiometabolic outcomes. Dietary patterns emphasizing plant-based foods, such as vegetarian and vegan diets, have been linked to a reduced risk of cardiovascular events and diabetes incidence. These diets provide high levels of dietary fiber and fermentable substrates that gut microbes ferment into short-chain fatty acids, which may modulate host health. Prebiotics and resistant starches are noted as dietary components that alter gut microbial composition.
Wong JM Am J Clin Nutr, 2014. PMID 24898225
2014 / Narrative review
This review discusses dietary clues in the pathogenesis of Crohn's disease, highlighting the effectiveness of exclusive enteral nutrition (EEN) in children and the requirement of complete exclusion of normal diet. The authors propose the 'bacterial penetration cycle' model, wherein dietary components such as animal fat, high sugar intake, gliadin, emulsifiers, maltodextrin, and low-fiber diets may induce a localized bacterial clearance defect. This defect potentially leads to bacterial adhesion, penetration, and gut inflammation.
Pfeffer-Gik T, Levine A Dig Dis, 2014. PMID 24969285
2014 / Review
This review evaluates the evidence supporting medication and management options for specific irritable bowel syndrome (IBS) symptoms. Several agents show evidence of symptom improvement, with rifaximin, lubiprostone, linaclotide, fiber supplementation (including psyllium and bran), and peppermint oil possessing the most reliable evidence supporting their use. Onset of efficacy occurred as early as 6 days after initiation, though efficacy for most medications was not assessed prospectively at predefined periods. Additional studies are noted to be needed to better define their place in therapy.
Trinkley KE, Nahata MC Digestion, 2014. PMID 24992947
2014 / Conference proceedings
The Food & Fiber Summit convened nutrition researchers, educators, and communicators to address persistently low fiber intake in America, which remains at approximately half of recommended amounts. Adequate fiber intake is associated with reduced risk for cardiovascular disease, cancer, diabetes, certain gastrointestinal disorders, and obesity. Summit outcomes emphasized addressing consumer confusion regarding fiber sources, recognizing benefits of various fiber types, and identifying practical opportunities across meal occasions and food categories to increase intake.
Shows an association, not proof of cause and effect.
Mobley AR, Jones JM, Rodriguez J, et al. Nutrients, 2014. PMID 25006857
2014 / Narrative review
This review evaluates evidence regarding dehydroepiandrosterone (DHEA) supplementation. Double-blind, placebo-controlled human trials in the elderly show DHEA increases monocytes, TCRγδ T cells, and NK cells, while improving well-being, muscle strength, bone density, and reducing body fat and skin atrophy. In adrenal insufficiency, it restores hormone levels, lowers total cholesterol, improves insulin sensitivity, and preserves bone mineral density. In women, DHEA improves sexual satisfaction, fertility, and vaginal atrophy, though studies remain inconsistent due to dosing differences, rapid metabolism, and other factors.
Rutkowski K, Sowa P, Rutkowska-Talipska J, et al. Drugs, 2014. PMID 25022952
2014 / Systematic review of randomized controlled trials
A systematic review identified four RCTs evaluating the effect of prunes on gastrointestinal function in constipated and non-constipated subjects. In constipation, 3 weeks of prunes (100 g/day) improved stool frequency (3.5 vs. 2.8 CSBM/week, P = 0.006) and consistency (3.2 vs. 2.8 on the Bristol stool form scale, P = 0.02) compared to psyllium (22 g/day). In non-constipated subjects, prunes softened stool consistency in one trial and increased stool weight (628 g vs. 514 g/72 h wet weight, P = 0.001) in another, with no differences in GI symptoms across trials. Meta-analysis was not appropriate due to heterogeneity, and two trials had unclear risk of bias.
Lever E, Cole J, Scott SM, et al. Aliment Pharmacol Ther, 2014. PMID 25109788
2014 / Narrative review
Mycobacterium avium subspecies paratuberculosis (MAP) causes Johne's disease (JD), a chronic granulomatous enteritis in ruminants. The histopathological picture of JD resembles Crohn's disease (CD), a human chronic inflammatory bowel disease of unresolved etiology. An etiological relevance of MAP for CD has been proposed, and this review discusses evidence regarding whether MAP possesses zoonotic capacity.
Atreya R, Bülte M, Gerlach GF, et al. Int J Med Microbiol, 2014. PMID 25128370
2014 / Narrative review
A literature search on PubMed evaluated clinical and animal studies examining the association between intestinal barrier dysfunction and CNS disorders such as schizophrenia, autism, neurodegenerative diseases, or depression. About half of the evaluated studies reported increased intestinal permeability or mucosal damage, with abnormally high sugar permeability markers reported in up to 43% of children with autism and up to 35% of schizophrenia patients, while another group found no differences. Some reports indicated diets like the gluten-free casein-free diet may normalize the lactulose/mannitol ratio in autism, but no adequately controlled study shows improvement in behavioural symptoms.
Shows an association, not proof of cause and effect.
Julio-Pieper M, Bravo JA, Aliaga E, et al. Aliment Pharmacol Ther, 2014. PMID 25262969
2014 / Narrative review
This review evaluated whether a strict vegan diet provides health advantages compared to vegetarian or overall healthy diets through the gut microbiota. Across studies, the relationship between diet and intestinal microbiota appears to follow a continuum, with vegans showing a microbiota profile most distinct from omnivores, though not always significantly different from vegetarians. The vegan profile uniquely showed a reduced abundance of pathobionts and greater abundance of protective species, with reduced inflammation proposed as a key linking feature. However, it remains unclear whether a therapeutic vegan diet can be prescribed to alter gut microflora for long-term health benefits.
Glick-Bauer M, Yeh MC Nutrients, 2014. PMID 25365383
2014 / Narrative review
This review summarizes current knowledge regarding the mucosal barrier and its role in disease prevention and therapy. It defines intestinal barrier and permeability, details elements affecting permeability, and depicts how diet, bacteria, nutrients, drugs, and other lifestyle factors regulate it. It discusses assessment methods and notes that increased intestinal permeability is associated with critical illness, inflammatory bowel diseases, celiac disease, food allergy, irritable bowel syndrome, and obesity and metabolic diseases.
Bischoff SC, Barbara G, Buurman W, et al. BMC Gastroenterol, 2014. PMID 25407511
2014 / Commentary
This commentary discusses research by Suez et al. (2014) examining the physiological roles of intestinal microbial communities, including energy harvest, glucose homeostasis, and immune development. It highlights their demonstration that artificial sweeteners alter gut microbial communities, resulting in glucose intolerance in both mice and humans.
Bokulich NA, Blaser MJ Cell Metab, 2014. PMID 25440050
2014 / Narrative review
This review provides an updated census of archaeal diversity in the human gastrointestinal tract and their possible role in gut physiology and health. It highlights the order Methanomassiliicoccales, associated with aged populations, which uses mono-, di-, and trimethylamine as final electron acceptors. Trimethylamine is a microbiota-derived product of dietary nutrients (lecithin, choline, TMAO, L-carnitine) from which trimethylaminuria and cardiovascular disease seem to originate via its oxidized liver-derived form. These characteristics support interest in exploring these methanogenic species as archaebiotics.
Gaci N, Borrel G, Tottey W, et al. World J Gastroenterol, 2014. PMID 25473158
2013 / Narrative review
This review examines the epidemiology of Clostridium difficile infection (CDI) in humans and animals. C. difficile has been found in 20-40% of meat products in Canada and the USA, indicating possible food-borne transmission, though not proven. PCR ribotype 078 is the most common ribotype in pigs (83% in one US study) and cattle (up to 100%), and is the third most common ribotype in human infection in Europe, where human and pig strains are genetically identical. The authors suggest that a 'One Health' approach is needed to address human, animal, and environmental factors.
Shows an association, not proof of cause and effect.
Squire MM, Riley TV Curr Top Microbiol Immunol, 2013. PMID 22695920
2013 / Narrative review
This review examines the chemical constituents, biological activities, molecular targets, and clinical potential of turmeric. Curcumin constitutes 2-5% of turmeric, though some activities of turmeric are curcumin-independent. Clinical trials have demonstrated the efficacy of turmeric against human ailments including lupus nephritis, cancer, diabetes, irritable bowel syndrome, acne, and fibrosis.
Gupta SC, Sung B, Kim JH, et al. Mol Nutr Food Res, 2013. PMID 22887802